ANDA 80027, held by Alcon Laboratories. Proparacaine Hydrochloride.
As of Nov 22, 2026, ANDA 80027 (Alcaine), held by Alcon Laboratories, was first approved by FDA on Dec 22, 1971, with 24 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE: ALCAINE ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 22, 1971 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Alcaine0.5% · solution/drops;ophthalmic | Proparacaine Hydrochloride | Rx |
| May 30, 2024 | Supplement 51Labeling · Standard review | Approved | None posted |
| Sep 9, 2022 | Supplement 47Labeling · Standard review | Approved | None posted |
| Apr 4, 2005 | Supplement 35Labeling | Approved | None posted |
| Aug 6, 2003 | Supplement 33Labeling | Approved | None posted |
| Dec 23, 2002 | Supplement 32Manufacturing | Approved | None posted |
| Mar 1, 2001 | Supplement 31Manufacturing | Approved | None posted |
| Mar 1, 2001 | Supplement 30Manufacturing | Approved | None posted |
| Aug 11, 2000 | Supplement 29Labeling | Approved | None posted |
| Aug 11, 2000 | Supplement 23Manufacturing | Approved | None posted |
| Apr 28, 2000 | Supplement 28Manufacturing | Approved | None posted |
| May 7, 1999 | Supplement 25Manufacturing | Approved | None posted |
| Apr 21, 1999 | Supplement 27Manufacturing | Approved | None posted |
| Mar 23, 1999 | Supplement 26Manufacturing | Approved | None posted |
| Mar 4, 1999 | Supplement 24Manufacturing | Approved | None posted |
| Jun 14, 1996 | Supplement 22Labeling | Approved | None posted |
| Oct 5, 1995 | Supplement 21Manufacturing | Approved | None posted |
| Aug 4, 1995 | Supplement 20Manufacturing | Approved | None posted |
| Jun 4, 1993 | Supplement 18Manufacturing | Approved | None posted |
| Jun 4, 1993 | Supplement 17Manufacturing | Approved | None posted |
| Apr 5, 1993 | Supplement 19Labeling | Approved | None posted |
| Dec 21, 1989 | Supplement 16Labeling | Approved | None posted |
| May 17, 1989 | Supplement 15Labeling | Approved | None posted |
| Apr 27, 1989 | Supplement 14Manufacturing | Approved | None posted |
| Jun 17, 1987 | Supplement 13Manufacturing | Approved | None posted |
| Dec 22, 1971 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters